» Articles » PMID: 34561194

Derivation and Validation of a Risk Score for Admission to the Intensive Care Unit in Patients with COVID-19

Overview
Specialty General Medicine
Date 2021 Sep 25
PMID 34561194
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This work aims to identify and validate a risk scale for admission to intensive care units (ICU) in hospitalized patients with coronavirus disease 2019 (COVID-19).

Methods: We created a derivation rule and a validation rule for ICU admission using data from a national registry of a cohort of patients with confirmed SARS-CoV-2 infection who were admitted between March and August 2020 (N = 16,298). We analyzed the available demographic, clinical, radiological, and laboratory variables recorded at hospital admission. We evaluated the performance of the risk score by estimating the area under the receiver operating characteristic curve (AUROC). Using the β coefficients of the regression model, we developed a score (0-100 points) associated with ICU admission.

Results: The mean age of the patients was 67 years; 57% were men. A total of 1420 (8.7%) patients were admitted to the ICU. The variables independently associated with ICU admission were age, dyspnea, Charlson Comorbidity Index score, neutrophil-to-lymphocyte ratio, lactate dehydrogenase levels, and presence of diffuse infiltrates on a chest X-ray. The model showed an AUROC of 0.780 (CI: 0.763-0.797) in the derivation cohort and an AUROC of 0.734 (CI: 0.708-0.761) in the validation cohort. A score of greater than 75 points was associated with a more than 30% probability of ICU admission while a score of less than 50 points reduced the likelihood of ICU admission to 15%.

Conclusion: A simple prediction score was a useful tool for forecasting the probability of ICU admission with a high degree of precision.

Citing Articles

Validation of the COVID-19-12O score for predicting readmissions/revisits in patients with SARS-CoV-2 pneumonia discharged from the emergency department.

Espinosa B, Ruso N, Ramos-Rincon J, Moreno-Perez O, Llorens P Rev Clin Esp (Barc). 2023; 223(4):244-249.

PMID: 36870418 PMC: 9979700. DOI: 10.1016/j.rceng.2023.03.001.


[Validation of the COVID-19-12O score for predicting readmissions/revisits in patients with SARS-CoV-2 pneumonia discharged from the emergency department].

Espinosa B, Ruso N, Ramos-Rincon J, Moreno-Perez O, Llorens P Rev Clin Esp. 2023; 223(4):244-249.

PMID: 36713824 PMC: 9874049. DOI: 10.1016/j.rce.2023.01.006.

References
1.
Ferrando C, Mellado-Artigas R, Gea A, Arruti E, Aldecoa C, Bordell A . Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study. Rev Esp Anestesiol Reanim (Engl Ed). 2020; 67(8):425-437. PMC: 7357496. DOI: 10.1016/j.redar.2020.07.003. View

2.
Guidet B, de Lange D, Boumendil A, Leaver S, Watson X, Boulanger C . The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study. Intensive Care Med. 2019; 46(1):57-69. PMC: 7223711. DOI: 10.1007/s00134-019-05853-1. View

3.
Berenguer J, Ryan P, Rodriguez-Bano J, Jarrin I, Carratala J, Pachon J . Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020; 26(11):1525-1536. PMC: 7399713. DOI: 10.1016/j.cmi.2020.07.024. View

4.
Allenbach Y, Saadoun D, Maalouf G, Vieira M, Hellio A, Boddaert J . Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients. PLoS One. 2020; 15(10):e0240711. PMC: 7571674. DOI: 10.1371/journal.pone.0240711. View

5.
Liang W, Liang H, Ou L, Chen B, Chen A, Li C . Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020; 180(8):1081-1089. PMC: 7218676. DOI: 10.1001/jamainternmed.2020.2033. View